We are live on !
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
Turnover
23.21%
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter Est. Return
+23.53%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$221M
AUM Growth
+$50.5M
(+30%)
Cap. Flow
+$20.5M
Cap. Flow % of AUM
Cap. Flow %
9.26%
Top 10 Holdings %
Top 10 Hldgs %
55.64%
Holding
119
New
19
Increased
16
Reduced
14
Closed
9
Avg Time Held
2.9
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDWT
Midwest Holding Inc. Common Stock
MDWT
|
+$8.29M |
| 2 |
Danimer Scientific, Inc.
DNMR
|
+$6.71M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$4.06M |
| 4 |
Gilead Sciences
GILD
|
+$3.25M |
| 5 |
Eastern Bankshares
EBC
|
+$2.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stericycle Inc
SRCL
|
+$10.1M |
| 2 |
LKQ Corp
LKQ
|
+$1.03M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
+$917K |
| 4 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$781K |
| 5 |
Pfizer
PFE
|
+$701K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.46% |
| 2 | Financials | 19.6% |
| 3 | Materials | 10% |
| 4 | Technology | 8.95% |
| 5 | Industrials | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
JPMorgan Chase
JPM
$902B
| $2.54M | 1.15% |
19,970
-3,080
| -13% | -$344K |
2013 Q2
30 quarters
|
|
27
Aurinia Pharmaceuticals
AUPH
$2.2B
| $2.46M | 1.11% |
177,540
+42,940
| +32% | +$625K |
2020 Q1
3 quarters
|
|
|
ZGNX
28
DELISTED
Zogenix, Inc.
ZGNX
| $2.25M | 1.02% |
112,707
| – | – |
2020 Q1
3 quarters
|
|
29
MPLX
MPLX
$59B
| $2.16M | 0.98% |
100,000
| – | – |
2018 Q1
11 quarters
|
|
|
HZAC
30
DELISTED
Horizon Acquisition Corporation
HZAC
| $2.1M | 0.95% |
+210,100
| New | +$2.11M |
2020 Q4
0 quarters
|
|
31
Joby Aviation
JOBY
$4.64B
| $2.04M | 0.92% |
+176,226
| New | +$1.96M |
2020 Q4
0 quarters
|
|
32
Brightstar Lottery PLC
BRSL
$1.74B
| $1.82M | 0.82% |
107,500
| – | – |
2019 Q1
7 quarters
|
|
33
Coherus Oncology
CHRS
$153M
| $1.77M | 0.8% |
101,655
+2,162
| +2% | +$38.5K |
2017 Q2
14 quarters
|
|
34
AllianceBernstein
AB
$3.21B
| $1.71M | 0.77% |
50,500
| – | – |
2013 Q2
30 quarters
|
|
|
ALXN
35
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.65M | 0.75% |
10,545
-1,455
| -12% | -$187K |
2020 Q3
1 quarter
|
|
|
36
BioCryst Pharmaceuticals
BCRX
$1.99B
| $1.64M | 0.74% |
219,461
-177,900
| -45% | -$917K |
2020 Q1
3 quarters
|
|
|
BDSI
37
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.56M | 0.7% |
370,230
-111,700
| -23% | -$430K |
2018 Q1
11 quarters
|
|
|
VAPO
38
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $1.32M | 0.6% |
6,125
| – | – |
2020 Q3
1 quarter
|
|
39
uniQure
QURE
$1.51B
| $1.26M | 0.57% |
35,000
+4,000
| +13% | +$169K |
2019 Q4
4 quarters
|
|
40
Viking Therapeutics
VKTX
$3.2B
| $1.23M | 0.56% |
218,102
| – | – |
2017 Q4
12 quarters
|
|
41
Verizon
VZ
$186B
| $1.08M | 0.49% |
18,311
| – | – |
2014 Q2
26 quarters
|
|
42
Johnson & Johnson
JNJ
$616B
| $956K | 0.43% |
6,080
-1,200
| -16% | -$177K |
2013 Q2
30 quarters
|
|
|
CNST
43
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $950K | 0.43% |
+33,000
| New | +$831K |
2020 Q4
0 quarters
|
|
44
Mondelez International
MDLZ
$81.6B
| $930K | 0.42% |
15,900
| – | – |
2013 Q2
30 quarters
|
|
45
Verrica Pharmaceuticals
VRCA
$61.8M
| $881K | 0.4% |
7,659
+3,046
| +66% | +$280K |
2019 Q2
6 quarters
|
|
46
DuPont de Nemours
DD
$17.6B
| $861K | 0.39% |
9,654
| – | – |
2015 Q1
23 quarters
|
|
47
Ryman Hospitality Properties
RHP
$8.69B
| $840K | 0.38% |
12,400
| – | – |
2013 Q2
30 quarters
|
|
48
DELISTED
Cidara Therapeutics
CDTX
| $831K | 0.38% |
20,765
+412
| +2% | +$20.5K |
2019 Q2
6 quarters
|
|
49
Kimberly-Clark
KMB
$35.1B
| $809K | 0.37% |
6,000
| – | – |
2017 Q3
13 quarters
|
|
50
Coca-Cola
KO
$404B
| $735K | 0.33% |
13,400
| – | – |
2013 Q2
30 quarters
|
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q4 2020 Portfolio in Review
As of Q4 2020, David M. Knott held 119 positions worth $221M, up 30% from $170M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
David M. Knott deployed $20.5M of net new capital in Q4 2020, opening 19 new positions and adding to 16 existing holdings. Its largest new stake was Midwest Holding Inc. Common Stock: 143,621 shares worth $7.7M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 42% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was LKQ Corp, an estimated $1.03M trimmed.
- David M. Knott's largest Q4 2020 buy was Midwest Holding Inc. Common Stock: 143,621 shares worth $7.7M.
- David M. Knott added most to Gilead Sciences in Q4 2020, an estimated $3.25M increase.
- David M. Knott's biggest Q4 2020 reduction was LKQ Corp, cutting an estimated $1.03M.
- David M. Knott fully exited Stericycle Inc in Q4 2020, selling an estimated $10.1M.
- David M. Knott's ten largest holdings make up 56% of its $221M portfolio in Q4 2020.
- David M. Knott opened 19 new positions and closed 9 in Q4 2020.
- David M. Knott's portfolio value rose 30% quarter-over-quarter to $221M.
Based on David M. Knott's 13F filing for Q4 2020, filed 12 Feb 2021.